February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Applications are open for the CCI4EU Second Capacity Building Conference – OECI
Jan 23, 2025, 09:41

Applications are open for the CCI4EU Second Capacity Building Conference – OECI

Organisation of European Cancer Institutes shared their earlier post on LinkedIn, adding:

“Time is running out!

The deadline to apply for the CCI4EU Second Capacity Building Conference is just around the corner – February 2, 2025!

Don’t miss your chance to be part of this transformative event, happening April 9–10, 2025, in Brussels. Collaborate with experts, explore innovative solutions, and contribute to shaping the future of Comprehensive Cancer Infrastructures.

Apply now.”

Quoting OECI’s earlier post:

“Mark your calendars for the CCI4EU Second Capacity Building Conference: ‘Accelerating Cancer Research and Innovation in Comprehensive Cancer Infrastructures’. The event will take place on April 9-10, 2025, at the Fondation Universitaire in Brussels.

Learn more and register.

This conference is the second of three that will be held over the course of the project. It will give individuals and teams from developing CCIs direction in helping them build their capacity and develop their infrastructures.

The conference will be a combination of lectures by international experts, discussions and breakout sessions aiming at:

  • Understanding the importance of capacity building in research and innovation.
  • Learning how to develop/improve biobanking, registries and screening programmes.
  • Identifying the ways to bring research findings into clinical settings.
  • Enhancing collaboration between stakeholders and other research centres.
  • Exploring real-world case studies and examples of successful/unsuccessful of ongoing research, innovation and patent cases.

Click here to learn more and to register.

Go to the CCI4EU website.”

Applications are open for the CCI4EU Second Capacity Building Conference - OECI

More posts featuring OECI.